Literature DB >> 9150511

Cognitive deficits distinguish patients with adolescent- and adult-onset schizophrenia.

M R Basso1, H A Nasrallah, S C Olson, R A Bornstein.   

Abstract

Recent studies have shown that patients with schizophrenia who have an adolescent-symptom onset (before age 21) have a worse clinical course and greater frequency of cerebral abnormalities than those with an adult-onset (after age 25). However, little is known about the neuropsychological functioning of these groups. A comprehensive neuropsychological examination was administered to groups of patients with schizophrenia with either an adolescent- or adult symptom-onset and a healthy control group. The adolescent-onset group performed worse than the adult-onset and control groups, particularly on measures of memory and executive function. The adult-onset group also performed worse than the controls, but to a lesser extent than did the adolescent-onset group. Results are discussed with reference to hypotheses that adolescent-onset schizophrenia represents a distinct neurodevelopmental disease entity.

Entities:  

Mesh:

Year:  1997        PMID: 9150511

Source DB:  PubMed          Journal:  Neuropsychiatry Neuropsychol Behav Neurol        ISSN: 0894-878X


  11 in total

1.  Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia.

Authors:  Serge Sevy; Delbert G Robinson; Barbara Napolitano; Raman C Patel; Handan Gunduz-Bruce; Rachel Miller; Joanne McCormack; Beth S Lorell; John Kane
Journal:  Schizophr Res       Date:  2010-05-14       Impact factor: 4.939

2.  Cognitive function in early onset schizophrenia: a selective review.

Authors:  Sophia Frangou
Journal:  Front Hum Neurosci       Date:  2010-01-29       Impact factor: 3.169

Review 3.  Clinical high risk for psychosis in children and adolescents: a systematic review.

Authors:  Jordina Tor; Montserrat Dolz; Anna Sintes; Daniel Muñoz; Marta Pardo; Elena de la Serna; Olga Puig; Gisela Sugranyes; Inmaculada Baeza
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-09-15       Impact factor: 4.785

4.  Using latent class growth analysis to form trajectories of premorbid adjustment in schizophrenia.

Authors:  Veronica T Cole; José A Apud; Daniel R Weinberger; Dwight Dickinson
Journal:  J Abnorm Psychol       Date:  2012-01-16

5.  Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients.

Authors:  Ann E Maloney; Linmarie Sikich
Journal:  Neuropsychiatr Dis Treat       Date:  2010-11-10       Impact factor: 2.570

6.  Neuropsychological functioning in early-onset first-episode psychosis: comparison of diagnostic subgroups.

Authors:  Arantzazu Zabala; Marta Rapado; Celso Arango; Olalla Robles; Elena de la Serna; Cristina González; José Manuel Rodríguez-Sánchez; Patricia Andrés; María Mayoral; Igor Bombín
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-09-19       Impact factor: 5.270

Review 7.  A systematic review of the long-term outcome of early onset schizophrenia.

Authors:  Lars Clemmensen; Ditte Lammers Vernal; Hans-Christoph Steinhausen
Journal:  BMC Psychiatry       Date:  2012-09-19       Impact factor: 3.630

8.  Psychosis in children: diagnosis and treatment.

Authors:  H Courvoisie; M J Labellarte; M A Riddle
Journal:  Dialogues Clin Neurosci       Date:  2001-06       Impact factor: 5.986

9.  Disrupted Working Memory Circuitry in Adolescent Psychosis.

Authors:  Ariel Eckfeld; Katherine H Karlsgodt; Kristen M Haut; Peter Bachman; Maria Jalbrzikowski; Jamie Zinberg; Theo G M van Erp; Tyrone D Cannon; Carrie E Bearden
Journal:  Front Hum Neurosci       Date:  2017-08-08       Impact factor: 3.169

10.  Comparing the ability of cognitive and affective Theory of Mind in adolescent onset schizophrenia.

Authors:  Dandan Li; Xiaosi Li; Fengqiong Yu; Xingui Chen; Long Zhang; Dan Li; Qiang Wei; Qing Zhang; Chunyan Zhu; Kai Wang
Journal:  Neuropsychiatr Dis Treat       Date:  2017-03-27       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.